Short-Term Debt to Capital: Dentsply Sirona Inc (XRAY)

Corporate company logo of DENTSPLY SIRONA Inc. (XRAY)

DENTSPLY SIRONA Inc. (XRAY) is a recognized global expert in dental equipment, trusted by medical professionals worldwide for its quality and safety; this price chart shows the metric at 0.03. The business operates within a strict oligopoly, facing pricing pressure from Asian suppliers. Meanwhile, the updated management team is successfully optimizing internal processes, restoring the company's reputation among investors.

XRAY - Dentsply Sirona Inc Short-Term Debt to Capital Coefficient over the range 07/04/2022 - 11/01/2026

Analytical breakdowns for DENTSPLY SIRONA Inc.

- stock quotes and analyst forecast:
Stock Price Dentsply|XRAY - Average Forecast Price
- company stock exchange capitalization indicators:
Market Capitalization Dentsply Sirona Inc|XRAY - Business Value
- book capitalization information:
Book Value per Share Dentsply Sirona|XRAY - Book Valuation of Business|Market Capitalization to Book Value Ratio dentsplysirona.com|XRAY - Cumulative Company Assets
- business debt structure and liquidity details:
Total Debt to Capital DENTSPLY SIRONA Inc.|XRAY - Long-Term Debt to Capital|Short-Term Debt to Equity Dentsply Sirona|XRAY - Company Debts|Debt to Book Value Dentsply Sirona Inc|XRAY - Company Long-Term Loans and Borrowings|Company Short-Term Debts Dentsply Sirona|Quick Liquidity dentsplysirona.com
- earnings and market ratios statistics:
XRAY - Company Profit
General company analysis:Dentsply XRAY
Brand item of Dentsply Sirona

For DENTSPLY SIRONA Inc. (XRAY), investments in dental robotics and AI software require flexible liquidity management, which is reflected in the changing short-term debt-to-equity ratio. This metric compares liabilities maturing within one year to total equity, allowing for an assessment of the company's reliance on short-term borrowed financing and the resilience of its financial foundation.

Direct competitors

Short-Term Debt to Capital ISRG|DHR - Current Liabilities to Capital|Short-Term Debt to Capital BDX (Becton Dickinson & Co)|STE: Short-Term Debt to Capital Ratio|West Pharmaceutical Services, Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Baxter International Inc. BAX|MASI: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Stevanato Group Corp|TFX (Teleflex Incorporated) - Short-Term Debt to Capital|Short-Term Debt to Capital merit.com|Short-Term Debt to Equity Envista (NVST)|Short-Term Debt to Equity ICUI (ICU Medical Inc)|LeMaitre - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital ATRC|STAAR Surgical Company - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient ChromaDex Corp NAGE|ZimVie (ZIMV) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio ANGO|Short-Term Debt to Equity Cerus Corp|Teknova Inc (TKNO) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio MGRM (Monogram Technologies)|Short-Term Loans to Capital Ratio STSS|Short-Term Debt to Equity InfuSystem Holdings, Inc. INFU|Ratio of Short-Term Indebtedness to Capital UTMD|KRMD: Short-Term Debt to Equity Ratio|NYXH - Short-Term Debt to Capital|Microbot Medical Inc. (MBOT) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio pro-dex.com|ZTEK (Zentek) - Short-Term Debt to Capital|Current Liabilities to Capital Elutia Inc ELUT|Short-Term Debt to Equity Milestone Scientific Corp (MLSS)|NEXGEL Inc - Short-Term Debt to Capital Ratio|Retractable Technologies, Inc. - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio HBIO (Harvard Bioscience Inc.)|FEMY - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient MeihuaMed MHUA|POAI: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio CJMB|ATRI (Atrion Corporation) - Short-Term Debt to Capital|Current Liabilities to Capital neurometrix.com NURO